(RSV) vaccines from GSK and Pfizer for people aged 60 years and older, according to a recent CDC statement. The vaccines should be administered using shared clinical decision-making, meaning individuals can receive a single dose of the vaccine based on conversations with their health care ...
According to the CDC, the reccomendations made by the ACIP Work Group for RSV prevention in adults have met once a month since July 2023 to consider its suggestions for RSV vaccination in adults. The committee used the Evidence to Recommendation Framework to make its final ...
In July 2023, the widely accessed and utilizedMorbidity and Mortality Weekly Report (MMWR)from the CDC published the recommendations from the Advisory Committee on Immunization Practices (ACIP) on respiratory syncytial virus (RSV) vaccine and provided baseline statistics for RSV’s societal burden, rep...
The CDC panel's recommendation of Pfizer's maternal vaccine was based on data from a phase three trial on nearly 7,400 participants. But mothers received the shot 24 to 36 weeks into their pregnancy in the trial, which is a wider period than the approved dosing time frame. During the ...
5, the CDC reported that 37% of people 75 and older say they have ever received an RSV vaccine, and 13% said they will definitely get one. Among adults 60 to 74 years old, 24% said they’d been vaccinated for RSV, and 10% said they definitely will get the shot. Cases of RSV ...
Since the ACIP issued the first RSV vaccine recommendation for adults in 2023, the shared decision-making recommendation has proven problematic in clinical practice, Camille Kotton, MD, chair of the ACIP's Adult RSV Work Group, told the committee. "We have learned from feedback from healthcare...
"I want to remind everyone that we have one of the best vaccine safety systems in the world. We have the ability to rapidly acquire information, rapidly assess it, and act on it. We saw that during the COVID pandemic, that system is viable, and is in place," the CDC's Dr. José...
It also comes as ACIP’s RSV work group — a subcommittee of members, CDC staff, and outside experts — is mulling whether the CDC’s recommendation on who should get an RSV vaccine should change. The current policy, approved last fall, recommends the vaccine for people 60 ...
The recommendation was quickly accepted by CDC Director Mandy Cohen, meaning the Pfizer vaccine will soon hit the U.S. market.
2. CDC Announces Recommendation for RSV Vaccine in Older Adults. Pharmacy Times. News release. June 30, 2023. Accessed April 24, 2024. https://www.pharmacytimes.com/view/cdc-announces-recommendation-for-rsv-vaccine-in-older-adults. 3. FDA Accepts Priority Review Application for RSV Vaccine to...